Ribavirin Treatment for Crimean-Congo Hemorrhagic Fever Reply

被引：0

作者：

Izadi, Shahrokh ^{[1
]}

Salehi, Masoud ^{[1
]}

机构：

[1] Zahedan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Chabahar Int Branch, Chabahar, Iran

来源：

JAPANESE JOURNAL OF INFECTIOUS DISEASES | 2009年 / 62卷 / 06期

关键词：

SEROPREVALENCE; EFFICACY; THERAPY; IRAN;

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：486 / 486

页数：1

共 7 条

[1]

HOLAKOUIENAIENI H, 2004, IRAN IRAN J PUBLIC H, V33, P1

[2] EPIDEMIOLOGY OF TICK-BORNE CRIMEAN-CONGO HEMORRHAGIC-FEVER IN ASIA, EUROPE, AND AFRICA [J].

HOOGSTRAAL, H .

JOURNAL OF MEDICAL ENTOMOLOGY, 1979, 15 (04) :307-417

[3]

Izadi S, 2006, JPN J INFECT DIS, V59, P326

[4]

Izadi S, 2009, JPN J INFECT DIS, V62, P11

[5] Crimean-Congo hemorrhagic fever among health care workers in Iran: A seroprevalence study in two endemic regions [J].

Mardani, Masoud ;

Rahnavardi, Mohammad ;

Rajaeinejad, Mohsen ;

Naini, Kourosh Holakoui ;

Chinikar, Sadegh ;

Pourmalek, Farshad ;

Rostami, Mojtaba ;

Shahri, Mohammad Hashemi .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 76 (03) :443-445

[6] Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy [J].

Ozkurt, Z ;

Kiki, H ;

Erol, S ;

Erdem, F ;

Yilmaz, N ;

Partak, M ;

Gundogdu, M ;

Tasyaran, MA .

JOURNAL OF INFECTION, 2006, 52 (03) :207-215

[7]

Swanepoel R, 1998, ZOONOSES, P311

← 1 →